- Fasenra (benralizumab) approved in the US for treating eosinophilic granulomatosis with polyangiitis in adults
Wed Sep 18 05:02:15 -0000 2024 UTC– AstraZeneca’s Fasenra approved in the US for treating eosinophilic granulomatosis with polyangiitis.
Granulomatosis with polyangiitis (GPA), also known as Wegener’s disease, named after the German pathologist Friedrich Wegener, is a rheumatic systemic disease of the vascular system and is characterized by a necrotizing inflammation of the vessels.
The inflammation of the blood vessels results in an inadequate blood supply to the affected organs. In principle, any tissue can be affected.